Gilead CEO Named New PhRMA Board Chair; Inherits a Litany of…
The Pharmaceutical Research and Manufacturers of America (PhRMA) has had a board reshake, naming Gilead Sciences Chairman and CEO Daniel O’Day as…
See our Cookie Privacy Policy Here